Entry Detail



General Information

Database ID:exR0364605
RNA Name:ILF3
RNA Type:mRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):10654261End Site(bp):10692417
External Links:ENSG00000129351



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010422.3
chr19
12643831
12648397
-
AGO1
chr1
35869808
35930532
+
AC093525.2
chr16
2496032
2520218
+
AC105052.3
chr7
102637049
102671641
-
AC105052.1
chr7
102582523
102642869
-
ACY1
chr3
51983340
51989197
+
ADH5
chr4
99070978
99088801
-
ADARB1
chr21
45073853
45226560
+
ACTL6A
chr3
179562886
179588407
+
AGPAT2
chr9
136673143
136687457
-
AC005258.1
chr19
2269525
2341172
+
ALDOA
chr16
30064164
30070457
+
ABCA7
chr19
1039997
1065572
+
AASS
chr7
122073549
122144255
-
ABHD14A-ACY1
chr3
51974706
51989183
+
AL035078.4
chr11
31812391
32104665
+
ACOT7
chr1
6264269
6394391
-
AEN
chr15
88621337
88632281
+
AKR1A1
chr1
45550543
45570049
+
AGAP1
chr2
235494043
236131800
+
AL590132.1
chr1
210858125
211134146
-
ABCF1
chr6
30571393
30597179
+
AC011462.1
chr19
41350853
41425001
+
AC027796.3
chr17
3585149
3636249
-
ACTG1
chr17
81509971
81523847
-
AC124312.1
chr15
24955034
25000276
+
ACTB
chr7
5527148
5563784
-
AL031708.1
chr16
1632259
1686715
+
ACBD6
chr1
180269653
180502954
-
ABHD14B
chr3
51968510
51983409
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-147a
chr9
120244985
120245004
-
hsa-miR-27b-3p
chr9
95085505
95085525
+
hsa-miR-513a-5p
chrX
147213538
147213555
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010536.1
chr16
87693537
87696147
-
AC125807.2
chr12
3041437
3044950
+
AC132217.1
chr11
2129121
2129964
-
AC139149.1
chr17
81514047
81527776
+
AD000090.1
chr19
35557956
35581954
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.